Prediction of therapy response and monitoring of CRSwNP-Patients under Dupilumab with nasal differential cytology – a monocentric, prospective, clinical trial
Laryngo-Rhino-Otologie · 01.05.2023 · 102 (S 02 S 02) · S324
DOI: 10.1055/s-0043-1767549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2023. Verfasst von Zeynep Danisman und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
This study aims to investigate the cellular composition of the nasal mucous membranes and the inflammatory cells of patients suffering from chronic sinusitis with nasal polyps undergoing Dupilumab therapy. The correlation between nasal differential cytology and therapy response is investigated in order to evaluate the diagnostic value of differential cytology as a predictive marker for Dupilumab therapy and as a marker for therapy monitoring.
Methods
20 CRSwNP- Patients with the indication of Dupilumab therapy have been included in the study. In total, five study visits are conducted from the beginning of therapy in an interval of 3 months, with ambulatory nasal differential cytology. First, the samples were stained with the May-Grunwald-Giemsa method (MGG) and the percentage of cells is analyzed. An immunocytochemical (ICC) ECP- staining is performed to detect eosinophilic granulocytes after that. Additionally, during each study visit the polyp score, SNOT20 questionnaire and the total IgG concentration in peripheral blood were recorded.
Results
So far in both MGG and ICC- analysis a significant decrease of eosinophilic cells can be seen throughout the therapeutic process, which correlates with a decrease of the polyp score and the SNOT20 questionnaire (p
Zitieren
APA
Danisman, Z., Berndt, S., Takacs, Z., Solomayer, E., Schick, B., & Linxweiler, M. (2023). Prediction of therapy response and monitoring of CRSwNP-Patients under Dupilumab with nasal differential cytology – a monocentric, prospective, clinical trial. Laryngo-Rhino-Otologie, 102(S 02 S 02), S324. https://doi.org/10.1055/s-0043-1767549
Vancouver
Danisman Z, Berndt S, Takacs Z, Solomayer E, Schick B, Linxweiler M. Prediction of therapy response and monitoring of CRSwNP-Patients under Dupilumab with nasal differential cytology – a monocentric, prospective, clinical trial. Laryngo-Rhino-Otologie. 2023;102(S 02 S 02):S324. doi:10.1055/s-0043-1767549
BibTeX
@article{Danisman2023,
author = {Danisman, Zeynep and Berndt, Sabrina and Takacs, Zoltan and Solomayer, Erich-Franz and Schick, Bernhard and Linxweiler, Maximilian},
title = {Prediction of therapy response and monitoring of CRSwNP-Patients under Dupilumab with nasal differential cytology – a monocentric, prospective, clinical trial},
journal = {Laryngo-Rhino-Otologie},
year = {2023},
volume = {102},
number = {S 02 S 02},
pages = {S324},
doi = {10.1055/s-0043-1767549}
}
EUVIMED